# Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry: Draft Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/development-of-non-opioid-analgesics-for-acute-pain-draft-guidance-for-industry-draft-guidance-for-industry/713b2eb7-8a4f-499d-a0e2-6ff44a5ecff9

> FDA guidance document: Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry: Draft Guidance for Industry. Issue date: February 09, 2022. Get complete insights and analysis.

---

## Details

- Title: Development of Non-Opioid Analgesics for Acute Pain; Draft Guidance for Industry: Draft Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-02-09
- Comment Close Date: 2022-04-11
- Last Changed: 2022-02-16
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2021-N-0556">FDA-2021-N-0556</a>

## Related Documents

- [Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/opioid-analgesic-drugs-considerations-for-benefit-risk-assessment-framework-guidance-for-industry/c20377b8-3086-48cf-be2b-b9cd12520573)
- [Assessment of Pressor Effects of Drugs Guidance for Industry: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/assessment-of-pressor-effects-of-drugs-guidance-for-industry-draft-guidance-for-industry/35abdc27-8b6a-4eb0-ba74-78a4a3840a3d)
- [Development of Non-Opioid Analgesics for Chronic Pain: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/development-of-non-opioid-analgesics-for-chronic-pain-draft-guidance-for-industry/38dd6b2d-d805-429f-bd38-3ebf08581d86)